Skip to content
Review

Emerging trends and future outlook towards magnetic nanoparticles as frontiers in cancer immunotherapy.

Aug 2026 · Nanoscale · Vol 18, pp. 18769-18801 · 0 citations
Medicine

TL;DR

Recent advances in MNP-based cancer immunotherapy are covered, including their mechanisms of immune modulation, innovative design strategies, and integration with existing therapies.

Abstract

Magnetic nanoparticles (MNPs) are becoming significant assets in cancer immunotherapy. Their unique magnetic and surface-functional properties allow them to serve as multifunctional platforms capable of modulating immune responses at multiple levels. MNPs have the potential to enhance immune cell activation and targeting inside the tumor microenvironment. MNPs assist in transporting immune-stimulating agents and tumor antigens directly to antigen-presenting cells. This increases T cell activity and improves anti-tumor reactions. MNPs are additionally utilized to enhance checkpoint blockade and to overcome the immunosuppressive milieu that often hinders the therapeutic efficacy of immunotherapies. In certain preclinical models, MNPs facilitate local hyperthermia to stimulate local immune activation at tumor sites. The magnetic guidance of these nanoparticles also facilitates the delivery of cytotoxic lymphocytes such as CD8 T cells and natural killer (NK) cells to solid tumors, addressing the challenge of poor infiltration of immune effector cells into the tumor. Numerous designs currently integrate therapy with imaging for accurate monitoring of biodistribution. Although MNPs hold potential, challenges remain in terms of biodegradability, long-term biosafety, immune compatibility and clinical applications. This review covers recent advances in MNP-based cancer immunotherapy, including their mechanisms of immune modulation, innovative design strategies, and integration with existing therapies. It also discusses the current limitations and future perspectives that will guide the next generation of magnetically assisted immunotherapeutic platforms toward clinical success.

View source

Similar papers

Review Open access Sep 2026

Recent advances in tumor-activated prodrug nanoparticles for cancer immunotherapy

Numerous therapeutic agents have been demonstrated to initiate antitumor immune responses, thereby driving significant progress in cancer immunotherapy. However, clinical translation is severely limited by persistent challenges, including systemic toxicity, the immunosuppressive tumor microenvironment (TME), and low na...

Guan-Ran Wang, Kun Du, Di-Kai Sun et al. · 0 citations
Aug 2026

Self-assembled protein-aptamer nanoparticles for targeted cancer immunotherapy.

This study proposes a controllable in situ self-assembly strategy to construct FimH protein-based nanoparticles incorporating mIFP protein and PD-L1 aptamer, demonstrating potential for targeted protein delivery and tumor therapy.

Xuemei Wang, Shengbo Li, Tian Wang et al. · 0 citations
Aug 2026

Dual delivery of immunostimulatory oligonucleotides and doxorubicin by magnetic nanoparticles and metal-organic frameworks for antitumor immunotherapy.

A dual-nanocarrier strategy in which CpG ODN and DOX were separately formulated in functionalized magnetic nanoparticles and metal-organic frameworks, respectively provides a practical method for combining physicochemically incompatible therapeutic agents in cancer chemo-immunotherapy.

Jaesung Lim, H. Seo, Jun-Hyeok Han et al. · 0 citations
Review Aug 2026

Nano meets CAR-T: A new era in cancer immunotherapy.

This review article focuses on CAR-T cell bioengineering, antitumor mechanism of action, challenges and limitations, as well as the latest innovative nanotechnological solutions for complementing CAR-T cell immunotherapy.

Alaa Ibrahim, Maha Nasr · 1 citation
Review Open access 2026

Immunological Interactions of Carbon Nanomaterials: Translational Perspectives in Oncology Drug Development

Carbon nanomaterials have gained attention because of their unique physico-chemical properties, such as high surface area, structural versatility, and ease of functionalization, and are highlighted as potential strategies to improve targeting, reduce adverse effects, and facilitate integration with current immunotherap...

Davide Frumento, Ș. Țălu · 0 citations
Review Open access Sep 2026

New insights into breast cancer therapy: application and mechanisms of novel targeted nano-formulation

This review systematically summarizes targeted nanomedicines constructed from mainstream carriers, including polymeric, metallic, and biomimetic nanoparticles, and discusses the future prospects of artificial intelligence-assisted optimization strategies for nanomedicine development.

Rui-Chao Li, Ze-Yuan Sun, Si-Nian Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.